Pursuant to regulation 30 (read with Part A of schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we ....

INNOVA CAPTAB LIMITED Plot No. 320, Industrial Area, Phase-1, Panchkula, Pin-134113, Haryana, India. Phone: +91-172-4194500 22nd August, 2026 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Mumbai – 400001 Bandra Kurla Complex BSE Symbol: INNOVACAP Bandra (E), Mumbai – 400051 BSE Scrip Code: 544067 NSE Symbol: INNOVACAP Dear Sir/Madam, Subject: Outcome of the Board Meeting dated i.e. 21st August, 2026 Pursuant to regulation 30 (read with Part A of schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that the Board of Directors of Innova Captab Limited, at its meeting commenced on Friday, 21st August, 2026 at 23:16 hours (IST) has approved the following: A. Revision of the Company’s financial statements for the financial year 2025-26, resulting to which Company’s financial results are also revised accordingly and we are submitting following documents as per regulation 33 of the Listing Regulations: Approval of the Revised Audited (Standalone and Consolidated) Financial Results for the quarter and financial year ended 31st March, 2026: In terms of regulation 33 of the Listing Regulations and pursuant to the approval of the Board of Directors of the Company, we are enclosing herewith a copy of the following as Annexure 1: Consolidated: a. Revised Audited Financial Results for the quarter and financial year ended 31st March, 2026; b. Revised Statement of Assets and Liabilities as at 31st March, 2026; c. Revised Statement of Cash Flow for the financial year ended 31st March, 2026; d. Revised Independent Auditor’s Report for the quarter and financial year ended 31st March, 2026, received from the statutory auditors of the Company. Standalone: a. Revised Audited Financial Results for the quarter and financial year ended 31st March, 2026; b. Revised Statement of Assets and Liabilities as at 31st March, 2026; c. Revised Statement of Cash Flow for the financial year ended 31st March, 2026; d. Revised Independent Auditor’s Report for the quarter and financial year ended 31st March, 2026, received from the statutory auditors of the Company. Further, pursuant to the provisions of regulation 33(3)(d) of the Listing Regulations, a declaration of Unmodified Opinion signed by the Chief Financial Officer (“CFO”) of the Company, in respect of the Revised Audited (Standalone and Consolidated) Financial Results of the Company for the quarter and financial year ended 31st March, 2026, is also enclosed herewith as Annexure 2. Registered Office - 1513, 15th Floor, Satra Plaza CHS Ltd. Plot No. 19&20, Sector-19D, Vashi, Navi Mumbai-400703, Maharashtra, India. CIN - L24246MH2005PLC150371, email - mail@innovacaptab.com INNOVA CAPTAB LIMITED Plot No. 320, Industrial Area, Phase-1, Panchkula, Pin-134113, Haryana, India. Phone: +91-172-4194500 The Revised Audited (Standalone and Consolidated) Financial Results shall be made available on the website of the Company viz. www.innovacaptab.com. The same shall be treated as compliance with regulation 46 of the Listing Regulations. B. Approval of the brownfield expansion of the manufacturing facility situated at Baddi, Himachal Pradesh: In terms of regulation 30 of the Listing Regulations, the Board of Directors of the Company had approved a brownfield expansion of the existing Baddi manufacturing facility situated at 81-B, EPIP Phase-I, Jharmajri, Baddi, Himachal Pradesh, within the same premises, the details required to be furnished under regulation 30 of Listing Regulations read with SEBI circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 (“Master Circular”) dated 30th January, 2026 annexed as Annexure 3. The Board meeting commenced on 21st August, 2026 at 23:16 hours (IST) and concluded on 22nd August, 2026 at 00:25 hours (IST). This is for your information and record. Thanking you, Yours faithfully, For and on behalf of Innova Captab Limited Neeharika Shukla Company Secretary and Compliance Officer Encl.: As above Registered Office - 1513, 15th Floor, Satra Plaza CHS Ltd. Plot No. 19&20, Sector-19D, Vashi, Navi Mumbai-400703, Maharashtra, India. CIN - L24246MH2005PLC150371, email - mail@innovacaptab.com Annexure-1 BS R & Co. LLP Unit No. AS0SA 5th Floor, Elante Offices Plot No. 178-178A, Industrial Area Chartered Accountants Phase -1, Chandigarh - 160002 Tel: +91 172 672 3400 lndeoendent Auditor's Reoort To the Board of Directors of lnnova Captab Limited Report on the audit of the Revised Consolidated Annual Financial Results Opinion We have audited the accompanying revised consolidated annual financial results of lnnova Captab Limited (hereinafter referred to as the "Holding Company") and its subsidiaries (Holding Company and its subsidiaries together referred to as "the Group"), for the year ended 31 March 2026, attached herewith, being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations"). In our opinion and to the best of our information and according to the explanations given to us and based on the consideration of report of other auditor on separate audited financial statements of the subsidiary, the aforesaid revised consolidated annual financial results: a. include the annual financial results of the following entities 1. lnnova Captab Limited -Parent Company 2. Univentis Medicare Limited -Subsidiary 3. Sharon Bio-Medicine Limited -Step Down Subsidiary 4. Univentis Foundation -Subsidiary b. are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and c. give a true and fair view in conformity with the recognition and measurement principles laid down in the applicable Indian Accounting Standards, and other accounting principles generally accepted in India, of consolidated net profit and other comprehensive income and other financial information of the Group for the year ended 31 March 2026. Basis for Opinion We conducted our audit in accordance with the Standards on Auditing ("SAs") specified under section 143( 10) of the Companies Act, 2013 ("the Act"). Our responsibilities under those SAs are further described in the Auditor's Responsibilities for the Audit of the Revised Consolidated Annual Financial Results section of our report. We are independent of the Group in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act, and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us along with the consideration of report of the other auditor referred to in paragraph no. (b) of the "Other Matters" section below, is sufficient and appropriate to provide a basis for our opinion on the revised consolidated annual financial results. Management's and Board of Directors'/Board of Trustees' Responsibilities for the Revised Consolidated Annual Financial Results These revised consolidated annual financial results have been prepared on the basis of the revised consolidated annual financial statements. Registered Office: BS R & Co. (a partnership firm with Registration No. BA61223) converte • SR & Co. LL (a 14th Floor, Central B 1/v'ing and North C \/Ving, Nesco IT Park 4, Nesco Limited Liability Partnership with LLP Registration No. AAB-8181) with e ect from October 14, 2013 Center, Western Express Highway, Goregaon (East), Mumbai• 400063 Page 1 of 4 BS R & Co. LLP Independent Auditor's Report (Continued) lnnova Captab Limited The Holding Company's Management and the Board of Directors are responsible for the preparat [Showing first 8,000 characters — download PDF for full document]